Literature DB >> 25797338

Expression of vascular endothelial growth factor (VEGF) mRNA, VEGF receptor 2 (Flk-1) mRNA, and of VEGF co-receptor neuropilin (Nrp)-1 mRNA in brain tissue of aging Tg2576 mice by in situ hybridization.

Abebe Muche1, Marina Bigl2, Thomas Arendt3, Reinhard Schliebs3.   

Abstract

Vascular endothelial growth factor (VEGF) has been characterized as a heparin binding angiogenic growth factor displaying high specificity for endothelial cells. It is profoundly accumulated and co-localized with amyloid beta (Aβ) plaques in the brain of Alzheimer's disease patients. In order to examine the effect of Aβ plaques on the expression level of VEGF mRNA and its receptors, brain tissue of both transgenic Tg2576 and wild type mice at ages ranging from 13 to 22 months was subjected to in situ hybridization followed by densitometric assessment using computer-assisted image analysis. Strong expression of VEGF mRNA, fetal liver kinase (Flk)-1 mRNA, and neuropilin (Nrp)-1 mRNA in the piriform, entorhinal, somatosensory, frontal cortex and hippocampal formation of both transgenic and non-transgenic mice brain was detected. Developmentally, only expression of VEGF mRNA was increased with age in the entorhinal, and somatosensory cortex of wild type mice. In 20-month-old transgenic Tg2576 mice, up-regulation of VEGF mRNA, Flk-1 mRNA, and Nrp-1 mRNA transcripts was observed in the entorhinal cortex compared to age-matched wild type mice. Our data suggest up-regulation of VEGF mRNA, Flk-1 mRNA and Nrp-1 mRNA, at least in the entorhinal cortex at ages when Aβ deposition in Tg2576 is typically increasing.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Beta amyloid plaques; Flk-1 mRNA; Nrp-1 mRNA; Transgenic mouse brain; VEGF mRNA

Mesh:

Substances:

Year:  2015        PMID: 25797338     DOI: 10.1016/j.ijdevneu.2015.03.003

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  8 in total

1.  Phosphorylated Tau 181 Serum Levels Predict Alzheimer's Disease in the Preclinical Stage.

Authors:  Wei Qin; Fangyu Li; Longfei Jia; Qi Wang; Ying Li; Yiping Wei; Yan Li; Hongmei Jin; Jianping Jia
Journal:  Front Aging Neurosci       Date:  2022-06-13       Impact factor: 5.702

Review 2.  Vascular endothelial growth factor: a neurovascular target in neurological diseases.

Authors:  Christian Lange; Erik Storkebaum; Carmen Ruiz de Almodóvar; Mieke Dewerchin; Peter Carmeliet
Journal:  Nat Rev Neurol       Date:  2016-07-01       Impact factor: 42.937

3.  Exercise training ameliorates cognitive dysfunction in amyloid beta-injected rat model: possible mechanisms of Angiostatin/VEGF signaling.

Authors:  Aliasghar Zarezadehmehrizi; Junyoung Hong; Jonghae Lee; Hamid Rajabi; Reza Gharakhanlu; Naser Naghdi; Mohammad Azimi; Yoonjung Park
Journal:  Metab Brain Dis       Date:  2021-05-18       Impact factor: 3.584

4.  VEGFR2 alteration in Alzheimer's disease.

Authors:  Sun-Jung Cho; Moon Ho Park; Changsu Han; Keejung Yoon; Young Ho Koh
Journal:  Sci Rep       Date:  2017-12-18       Impact factor: 4.379

5.  Panax ginseng total protein promotes proliferation and secretion of collagen in NIH/3T3 cells by activating extracellular signal-related kinase pathway.

Authors:  Xuenan Chen; Manying Wang; Xiaohao Xu; Jianzeng Liu; Bing Mei; Pingping Fu; Daqing Zhao; Liwei Sun
Journal:  J Ginseng Res       Date:  2017-03-01       Impact factor: 6.060

6.  NR3C2 suppresses the proliferation, migration, invasion and angiogenesis of colon cancer cells by inhibiting the AKT/ERK signaling pathway.

Authors:  Jia Li; Zhao Xu
Journal:  Mol Med Rep       Date:  2022-02-22       Impact factor: 2.952

7.  Role of Nrp1 in controlling cortical inter-hemispheric circuits.

Authors:  Fernando Martín-Fernández; Ana Bermejo-Santos; Lorena Bragg-Gonzalo; Carlos G Briz; Esther Serrano-Saiz; Marta Nieto
Journal:  Elife       Date:  2022-03-01       Impact factor: 8.140

8.  The VEGF inhibitor vatalanib regulates AD pathology in 5xFAD mice.

Authors:  Seong Gak Jeon; Hyun-Ju Lee; HyunHee Park; Kyung-Min Han; Hyang-Sook Hoe
Journal:  Mol Brain       Date:  2020-09-25       Impact factor: 4.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.